For best results when printing this announcement, please click on link below:
http://newsfile.refinitiv.com/getnewsfile/v1/story?guid=urn:newsml:reuters.com:20230613:nRSM4710Ca&default-theme=true
RNS Number : 4710C Kosmos Energy Limited 13 June 2023
Kosmos Energy Ltd (the "Company")
PDMR Shareholding
NOTIFICATION AND PUBLIC DISCLOSURE IN ACCORDANCE WITH THE REQUIREMENTS OF THE
EU MARKET ABUSE REGULATION OF TRANSACTIONS BY PERSONS DISCHARGING MANAGERIAL
RESPONSIBILITIES
13 June 2023
The following Persons Discharging Managerial Responsibilities ("PDMRs") have
had changes in their shareholdings of Common Shares in the Company:
PDMR Date of transaction No. of shares vested No. of shares granted No. of shares sold or withheld
Roy A. Franklin 8 June 2023 0 24,964 0
Roy A. Franklin 9 June 2023 0 0 8,000
Deanna L. Goodwin 8 June 2023 0 24,964 0
Deanna L. Goodwin 9 June 2023 0 0 112,000
Sir John Douglas Kelso Grant 8 June 2023 0 24,964 0
Maria Moraeus Hanssen 8 June 2023 0 24,964 0
Adebayo O. Ogunlesi 8 June 2023 0 24,964 0
Steven M. Sterin 8 June 2023 0 24,964 0
J. Michael Stice 8 June 2023 0 24,964 0
The Notification of Dealing Form for each PDMR, which provides full details of
the transactions outlined above, can be found below.
This notification is made in accordance with Article 19 of the EU Market Abuse
Regulation.
Josh R. Marion
Vice President and Assistant Secretary
CONTACT:
Investor Relations
Jamie Buckland
+44 203 954 2831
jbuckland@kosmosenergy.com
Media Relations
Thomas Golembeski
+1-214-445-9674
tgolembeski@kosmosenergy.com
1. Details of PDMR / person closely associated with them ("PCA")
a) Name Roy A. Franklin
b) Position / status Director
c) Initial notification / amendment Initial notification
2. Details of the transaction(s): section to be repeated for (i) each type of
instrument; (ii) each type of transaction; (iii) each date; and (iv) each
place where transactions have been conducted
a) Description of the financial instrument Common Shares, par value $0.01 per share
b) Nature of the transactions 24,964 restricted share units granted to the reporting person on June 8, 2023
under the Issuer's Long Term Incentive Plan (the "Plan") and are scheduled to
vest 100% on the earlier of June 8, 2024 or the day immediately preceding the
date of the Issuer's first annual shareholder meeting following the date of
grant, subject to the terms of the Plan and the applicable award agreement
issued thereunder.
Shares granted or vested
c) Currency USD
Price 6.81
Volume 24,964
Total 170,004.84
Shares sold or withheld
d) Currency USD
Price 0
Volume 0
Total 0
Aggregated information
e)
Price 6.81
Volume 24,964
Total 170,004.84
f) Date of the transactions 8 June 2023
g) Place of the transaction NYSE
2. Details of the transaction(s): section to be repeated for (i) each type of
instrument; (ii) each type of transaction; (iii) each date; and (iv) each
place where transactions have been conducted
a) Description of the financial instrument Common Shares, par value $0.01 per share
b) Nature of the transactions 8,000 shares sold on June 9, 2023 to partially cover income tax liability from
the vesting of restricted share units granted to the reporting person under
the Plan.
Shares granted or vested
c) Currency USD
Price 0
Volume 0
Total 0
Shares sold or withheld
d) Currency USD
Price 6.80
Volume 8,000
Total 54,400
Aggregated information
e)
Price 6.80
Volume 8,000
Total 54,400
f) Date of the transactions 9 June 2023
g) Place of the transaction NYSE
1. Details of PDMR / person closely associated with them ("PCA")
a) Name Deanna L. Goodwin
b) Position / status Director
c) Initial notification / amendment Initial notification
2. Details of the transaction(s): section to be repeated for (i) each type of
instrument; (ii) each type of transaction; (iii) each date; and (iv) each
place where transactions have been conducted
a) Description of the financial instrument Common Shares, par value $0.01 per share
b) Nature of the transactions 24,964 restricted share units granted to the reporting person on June 8, 2023
under the Plan and are scheduled to vest 100% on the earlier of June 8, 2024
or the day immediately preceding the date of the Issuer's first annual
shareholder meeting following the date of grant, subject to the terms of the
Plan and the applicable award agreement issued thereunder.
Shares granted or vested
c) Currency USD
Price 6.81
Volume 24,964
Total 170,004.84
Shares sold or withheld
d) Currency USD
Price 0
Volume 0
Total 0
Aggregated information
e)
Price 6.81
Volume 24,964
Total 170,004.84
f) Date of the transactions 8 June 2023
g) Place of the transaction NYSE
2. Details of the transaction(s): section to be repeated for (i) each type of
instrument; (ii) each type of transaction; (iii) each date; and (iv) each
place where transactions have been conducted
a) Description of the financial instrument Common Shares, par value $0.01 per share
b) Nature of the transactions 112,000 shares sold on June 9, 2023 on the open market. The transaction was
executed in multiple trades at prices ranging from USD 6.65 to USD 6.73. The
price below of USD 6.69 reflects the weighted average purchase price.
Shares granted or vested
c) Currency USD
Price 0
Volume 0
Total 0
Shares sold or withheld
d) Currency USD
Price 6.69
Volume 112,000
Total 749,280
Aggregated information
e)
Price 6.69
Volume 112,000
Total 749,280
f) Date of the transactions 9 June 2023
g) Place of the transaction NYSE
1. Details of PDMR / person closely associated with them ("PCA")
a) Name Sir John Douglas Kelso Grant
b) Position / status Director
c) Initial notification / amendment Initial notification
2. Details of the transaction(s): section to be repeated for (i) each type of
instrument; (ii) each type of transaction; (iii) each date; and (iv) each
place where transactions have been conducted
a) Description of the financial instrument Common Shares, par value $0.01 per share
b) Nature of the transactions 24,964 restricted share units granted to the reporting person on June 8, 2023
under the Plan and are scheduled to vest 100% on the earlier of June 8, 2024
or the day immediately preceding the date of the Issuer's first annual
shareholder meeting following the date of grant, subject to the terms of the
Plan and the applicable award agreement issued thereunder.
Shares granted or vested
c) Currency USD
Price 6.81
Volume 24,964
Total 170,004.84
Shares sold or withheld
d) Currency USD
Price 0
Volume 0
Total 0
Aggregated information
e)
Price 6.81
Volume 24,964
Total 170,004.84
f) Date of the transactions 8 June 2023
g) Place of the transaction NYSE
1. Details of PDMR / person closely associated with them ("PCA")
a) Name Maria Moraeus Hanssen
b) Position / status Director
c) Initial notification / amendment Initial notification
2. Details of the transaction(s): section to be repeated for (i) each type of
instrument; (ii) each type of transaction; (iii) each date; and (iv) each
place where transactions have been conducted
a) Description of the financial instrument Common Shares, par value $0.01 per share
b) Nature of the transactions 24,964 restricted share units granted to the reporting person on June 8, 2023
under the Plan and are scheduled to vest 100% on the earlier of June 8, 2024
or the day immediately preceding the date of the Issuer's first annual
shareholder meeting following the date of grant, subject to the terms of the
Plan and the applicable award agreement issued thereunder.
Shares granted or vested
c) Currency USD
Price 6.81
Volume 24,964
Total 170,004.84
Shares sold or withheld
d) Currency USD
Price 0
Volume 0
Total 0
Aggregated information
e)
Price 6.81
Volume 24,964
Total 170,004.84
f) Date of the transactions 8 June 2023
g) Place of the transaction NYSE
1. Details of PDMR / person closely associated with them ("PCA")
a) Name Adebayo O. Ogunlesi
b) Position / status Director
c) Initial notification / amendment Initial notification
2. Details of the transaction(s): section to be repeated for (i) each type of
instrument; (ii) each type of transaction; (iii) each date; and (iv) each
place where transactions have been conducted
a) Description of the financial instrument Common Shares, par value $0.01 per share
b) Nature of the transactions 24,964 restricted share units granted to the reporting person on June 8, 2023
under the Plan and are scheduled to vest 100% on the earlier of June 8, 2024
or the day immediately preceding the date of the Issuer's first annual
shareholder meeting following the date of grant, subject to the terms of the
Plan and the applicable award agreement issued thereunder.
Shares granted or vested
c) Currency USD
Price 6.81
Volume 24,964
Total 170,004.84
Shares sold or withheld
d) Currency USD
Price 0
Volume 0
Total 0
e) Aggregated information
Price 6.81
Volume 24,964
Total 170,004.84
f) Date of the transactions 8 June 2023
g) Place of the transaction NYSE
1. Details of PDMR / person closely associated with them ("PCA")
a) Name Steven M. Sterin
b) Position / status Director
c) Initial notification / amendment Initial notification
2. Details of the transaction(s): section to be repeated for (i) each type of
instrument; (ii) each type of transaction; (iii) each date; and (iv) each
place where transactions have been conducted
a) Description of the financial instrument Common Shares, par value $0.01 per share
b) Nature of the transactions 24,964 restricted share units granted to the reporting person on June 8, 2023
under the Plan and are scheduled to vest 100% on the earlier of June 8, 2024
or the day immediately preceding the date of the Issuer's first annual
shareholder meeting following the date of grant, subject to the terms of the
Plan and the applicable award agreement issued thereunder.
Shares granted or vested
c) Currency USD
Price 6.81
Volume 24,964
Total 170,004.84
Shares sold or withheld
d) Currency USD
Price 0
Volume 0
Total 0
e) Aggregated information
Price 6.81
Volume 24,964
Total 170,004.84
f) Date of the transactions 8 June 2023
g) Place of the transaction NYSE
1. Details of PDMR / person closely associated with them ("PCA")
a) Name J. Michael Stice
b) Position / status Director
c) Initial notification / amendment Initial notification
2. Details of the transaction(s): section to be repeated for (i) each type of
instrument; (ii) each type of transaction; (iii) each date; and (iv) each
place where transactions have been conducted
a) Description of the financial instrument Common Shares, par value $0.01 per share
b) Nature of the transactions 24,964 restricted share units granted to the reporting person on June 8, 2023
under the Plan and are scheduled to vest 100% on the earlier of June 8, 2024
or the day immediately preceding the date of the Issuer's first annual
shareholder meeting following the date of grant, subject to the terms of the
Plan and the applicable award agreement issued thereunder.
Shares granted or vested
c) Currency USD
Price 6.81
Volume 24,964
Total 170,004.84
Shares sold or withheld
d) Currency USD
Price 0
Volume 0
Total 0
e) Aggregated information
Price 6.81
Volume 24,964
Total 170,004.84
f) Date of the transactions 8 June 2023
g) Place of the transaction NYSE
This information is provided by RNS, the news service of the London Stock Exchange. RNS is approved by the Financial Conduct Authority to act as a Primary Information Provider in the United Kingdom. Terms and conditions relating to the use and distribution of this information may apply. For further information, please contact
rns@lseg.com (mailto:rns@lseg.com)
or visit
www.rns.com (http://www.rns.com/)
.
RNS may use your IP address to confirm compliance with the terms and conditions, to analyse how you engage with the information contained in this communication, and to share such analysis on an anonymised basis with others as part of our commercial services. For further information about how RNS and the London Stock Exchange use the personal data you provide us, please see our
Privacy Policy (https://www.lseg.com/privacy-and-cookie-policy)
. END DSHSFFFUEEDSEIM